Skip to content

Markers of excess weight, weight loss and weight regain in candidates for surgical treatment of obesity

Reward-related gustatory and psychometric markers of excess weight, weight loss and weight regain in candidates for surgical treatment of obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN59323751
Enrollment
300
Registered
2020-07-06
Start date
2012-11-05
Completion date
Unknown
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity (Class II to III) Nutritional, Metabolic, Endocrine Obesity

Interventions

This cohort will include consecutive patients with obesity at three Portuguese tertiary care outpatient centers specialized in surgical treatment of obesity. Patients will be selected according to app

Sponsors

Champalimaud Research & Clinical Centre, Champalimaud Centre for the Unknown
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consecutive adult patients with obesity at three Portuguese tertiary care outpatient centers specialized in the surgical treatment of obesity, namely Hospital do Espírito Santo de Évora, Hospital de São Bernardo de Setúbal, and Centro Hospitalar Universitário de São João for bariatric surgery, following the criteria defined in the Portuguese National Health Service: 1. Body mass index (BMI) greater than 40 kg/m2 with or without associated comorbidities or greater than 35 Kg/m2 in the presence of at least 1 comorbidity (type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea syndrome, obese hypoventilation syndrome, arterial hypertension or osteoarticular degenerative pathology, with marked functional limitation). 2. Age between 18 and 65 years 3. Failure of non-surgical interventions for weight reduction, for at least one year, obesity that is not secondary to an identified endocrine disease 4. Ability to understand the surgical procedure and to adhere to a long-term follow-up program 5. Absence of psychiatric disorders, absence of alcohol or drug dependence 6. Balanced relationship between operative risk and clinical risk

Exclusion criteria

Exclusion criteria: 1. Active acute respiratory infection 2. Active neurological or psychiatric disease 3. Active gastrointestinal, hepatic or pancreatic disease 4. Illicit substance use or alcohol abuse 5. Illiteracy or otherwise not understanding instructions for the study 6. Prior major gastrointestinal surgery 7. Intra-gastric balloon 8. History of food allergies 9. Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Primary response (dependent) variable: Weight change from baseline [%WL = (weight lost/baseline weight)*100] assessed up to 18 months after surgery Main explanatory (independent) variables: 1. Mean intensity and pleasantness ratings given to four concentrations of sucrose (sweet) as assessed with general labeled magnitude scales (gLMS) at baseline up to 18 months after surgery 2. Hedonic hunger assessed with the Power of Food Scale assessed at baseline and up to 18 months after surgery 3. Addiction-like feeding behavior assessed with the Yale Food Addiction Scale assessed up to 18 months after surgery

Secondary

MeasureTime frame
Secondary explanatory (independent) variables: 1. Intensity and pleasantness ratings given to four concentrations of citric acid (sour) as assessed with a gLMS at baseline up to 18 months after surgery 2. Intensity and pleasantness ratings given to four concentrations of sodium chloride (salty) as assessed with a gLMS at baseline up to 18 months after surgery 3. Intensity and pleasantness ratings given to four concentrations of quinine hydrochloride (bitter) as assessed with a gLMS at baseline up to 18 months after surgery 4. Acuity in tastant identification (sour, salt, sweet and bitter) assessed in a multiple forced choice test, at baseline and up to 18 months after surgery 5. Taste thresholds assessed with electrogustometry at baseline and up to 18 months after surgery 6. Feeding behavior traits assessed by the Dutch Eating Behavior Questionnaire (DEBQ) assessed at baseline and up to 18 months after surgery 7. Food acceptance assessed by the Food Action Rating Scale (FARS) assessed at baseline and up to 18 months after surgery 8. Depressive symptom severity assessed with the Beck Depression Inventory II (BDI-II) assessed up to 18 months after surgery

Countries

Portugal

Contacts

Public ContactGabriela Ribeiro
gabriela.ribeiro@neuro.fchampalimaud.org+351 (0)21 048 0200

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026